Equillium
Lisette Acevedo has extensive experience in clinical development and project management in various pharmaceutical and biotech companies. Lisette has a strong background in preclinical drug development, market analysis, and out-licensing strategies. Lisette has a Ph.D. in Pharmacology from Yale University, an MBA from the University of California, San Diego, and a B.S. in Biochemistry from UC San Diego. Throughout their career, Lisette has successfully secured grants, published numerous articles, and presented at international conferences. Lisette's expertise in drug development and business management makes their a valuable asset in the pharmaceutical industry.
This person is not in the org chart
Equillium
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of patients with severe autoimmune and inflammatory diseases who continue to suffer with high unmet medical needs.